Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients
NCT03083756 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 577
Last updated 2017-03-20
Summary
This study validate the usefulness of SIMPLICITY score to characterize the immune status of the kidney transplant receiver at two points along its course (the one and six months after transplantation), by determination in peripheral blood of various parameters related to cellular immunity (count subpopulations of CD3+ (cluster of differentiation 3), CD4+ (cluster of differentiation 4) and CD8+( cluster of differentiation 8)), humoral immunity (immunoglobulins count) and innate (complement).
Conditions
- Opportunistic Infections
Sponsors & Collaborators
-
Roche Farma, S.A
collaborator INDUSTRY -
Sociedad Española de Trasplante
lead OTHER
Principal Investigators
-
José María Aguado, MD · Hospital Universitario 12 de Octubre
-
Daniel Serón, MD · Hospital Universitario Vall d´Hebrón
-
Ángel Alonso, MD · Hospital Universitario de A Coruña
-
Domingo Hernández Marrero, MD · Hospital Carlos Haya
-
Álex Gutiérrez Dalmau, MD · Hospital Miguel Servet
-
Roberto Gallego, MD · Hospital Dr. Negrín
-
Juan Carlos Ruiz, MD · Hospital Marqués de Valdecilla
-
Frederic Cofàn, MD · Hospital Clinic of Barcelona
-
José M Cruzado, MD · Hospital Universitari de Bellvitge
-
Daniel Serón, MD · Hospital Universitario Vall d´Hebrón
-
María José Pérez Sáez, MD · Hospital del Mar
-
Miguel Angel Muñoz Cepeda, MD · Hospital Virgen de la Salud
-
Ángel Alonso, MD · Hospital Universitario de A Coruña
-
Gonzalo Gómez, MD · Hospital Son Espases
-
Amado Andrés, MD · Hospital Universitario 12 de Octubre
-
José Mª Portolés, MD · Hospital Universitario Puerta de Hierro Majadahonda
-
Roberto Marcén, MD · Hospital Universitario Ramon y Cajal
-
Luisa Jimeno Garcia, MD · Hospital Virgen de la Arrixaca
-
Luis M Pallardó Mateu, MD · Hospital Dr. Peset
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2017-02-15
- Completion
- 2017-02-15
Countries
- Spain
Study Locations
More Related Trials
-
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
NCT03339661 ·Status: COMPLETED ·Phase: PHASE2
-
Urine CXCL10 Chemokine Monitoring Post-renal Transplant
NCT03140514 ·Status: COMPLETED ·Phase: NA
-
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
NCT04727788 ·Status: ACTIVE_NOT_RECRUITING
-
Urine Testing to Detect Kidney Transplant Rejection
NCT00337220 ·Status: COMPLETED
-
Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies
NCT05306795 ·Status: UNKNOWN
-
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965 ·Status: COMPLETED ·Phase: NA
-
Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation
NCT05890430 ·Status: NOT_YET_RECRUITING
-
Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes
NCT03474003 ·Status: COMPLETED
-
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
NCT01289717 ·Status: COMPLETED
-
Urinary Tract Infections in Kidney Transplant Recipients
NCT03211026 ·Status: UNKNOWN
-
Urine Biomarker for Kidney Transplant Rejection
NCT05072951 ·Status: NOT_YET_RECRUITING
-
Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
NCT06910527 ·Status: RECRUITING
-
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
NCT03977051 ·Status: COMPLETED
-
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
NCT06474169 ·Status: RECRUITING
-
Use of Wearables to Detect Infections in Kidney Transplant Recipients
NCT06364618 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Acute Rejection in Renal Transplant Patients by Urine Mass Spectrometry
NCT01315067 ·Status: COMPLETED
-
Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
NCT01443013 ·Status: COMPLETED
-
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
NCT06025240 ·Status: RECRUITING
-
Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
NCT03652402 ·Status: COMPLETED
-
Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"
NCT06406179 ·Status: RECRUITING ·Phase: NA
-
Immune Response in Desensitized Patients
NCT05785936 ·Status: UNKNOWN
-
Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)
NCT00746057 ·Status: TERMINATED ·Phase: NA
-
Cell-based Assays for Antibody-mediated Transplant Rejection
NCT03916822 ·Status: UNKNOWN
-
Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.
NCT05597540 ·Status: RECRUITING ·Phase: PHASE3
-
Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)
NCT01615900 ·Status: COMPLETED ·Phase: NA